Interaction of gender, hypertension, and the angiotensinogen gene haplotypes on the risk of coronary artery disease in a large angiographic cohort

Atherosclerosis

Volumn 203, Issue 1, 2009, Pages 249-256

  Tsai, Chia Ti ^a   Hwang, Juey Jen ^a   Lai, Ling Ping ^a   Wang, Yi Chih ^a   Lin, Jiunn Lee ^a   Chiang, Fu Tien ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coronary artery disease; Gene environment interaction; Genetics; Haplotype; Multilocus; Regression

Indexed keywords

ANGIOTENSINOGEN;

ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENDER; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANGIOGRAPHY; ANGIOTENSINOGEN; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HAPLOTYPES; HEART CATHETERIZATION; HUMANS; HYPERTENSION; MALE; MODELS, GENETIC; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK; SEX FACTORS;

EID: 60649117132     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.06.004     Document Type: Article

References (37)

1. Neri Serneri G.G., Boddi M., Modesti P.A., et al. Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component. Circ Res 94 (2004) 1630-1637
2. Reid I.A., Morris B.J., and Ganong W.J. The renin-angiotensin system. Annu Rev Physiol 40 (1978) 377-410
3. Sato N., Katsuya T., Nakagawa T., et al. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci 68 (2000) 259-272
4. Katsuya T., Koike G., Yee T.W., et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345 (1995) 1600-1603
5. Gardemann A., Stricker J., Humme J., et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis 145 (1999) 309-314
6. Tsai C.T., Fallin D., Chiang F.T., et al. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension 41 (2003) 9-15
7. Martin E.R., Lai E.H., Gilbert J.R., et al. SNPing away at complex disease: analysis of singe-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 67 (2000) 383-394
8. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 29 (2001) 233-237
9. Tsai C.T., Hwang J.J., Chiang F.T., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation: a regression approach for the detection of gene-gene interactions in a large hospitalized population. Cardiology 111 (2008) 1-7
10. Rios D.L., D'Onofrio L.O., Cerqueira C.C., et al. Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians. Clin Chem Lab Med 45 (2007) 874-878
11. Manfredi S., Federici C., Picano E., et al. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Mutat Res 621 (2007) 106-112
12. Abu-Amero K.K., Al-Mohanna F., Al-Boudari O.M., Mohamed G.H., and Dzimiri N. The interactive role of type 2 diabetes mellitus and E-selectin S128R mutation on susceptibility to coronary heart disease. BMC Med Genet (2007) 8-35
13. Tsai C.T., Hwang J.J., Ritchie M.D., et al. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 195 (2007) 172-180
14. Chien K.L., Sung F.C., Hsu H.C., et al. Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan: report of the Chin-Shan Community Cardiovascular Study. Stroke 33 (2002) 39-44
15. Tsai C.T., Lai L.P., Lin J.L., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640-1646
16. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
17. Lake S.L., Lyon H., Tantisira K., et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55 (2003) 56-65
18. Chatterjee N., Kalaylioglu Z., Moslehi R., Peters U., and Wacholder S. Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. Am J Hum Genet 79 (2006) 1002-1016
19. Millstein J., Conti D.V., Gilliland F.D., and Gauderman W.J. A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet 78 (2006) 15-27
20. Long J., Williams R., and Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotype. Am J Hum Genet 56 (1995) 799-810
21. Fallin D., and Schork N.J. Accuracy of haplotype frequency estimation for biallelic loci via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 67 (2000) 947-959
22. Mantel N., and Fleiss J.L. Minimum expected cell size requirements for the Mantel-Haenszel one-degree-of-freedom Chi-square test and a related rapid procedure. Am J Epidemiol 112 (1980) 129-134
23. Howson J.M., Barratt B.J., Todd J.A., and Cordell H.J. Comparison of population- and family-based methods for genetic association analysis in the presence of interacting loci. Genet Epidemiol 29 (2005) 51-67
24. Fornage M., Amos C.I., Kardia S., et al. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 97 (1998) 1773-1779
25. O'Donnell C.J., Lindpaintner K., Larson M.G., et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97 (1998) 1766-1772
26. Kimura M., Yokota M., Fujimura T., et al. Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1919 subjects. Cardiology 88 (1997) 309-314
27. Kaplinsky E. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. Cardiovasc Drugs Ther 8 Suppl. 3 (1994) 549-556
28. Oelkers W.K. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61 (1996) 166-171
29. Sealey J.E., Itskovitz-Eldor J., Rubattu S., et al. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab 79 (1994) 258-264
30. Feldmer M., Kaling M., Takahashi S., Mullins J.J., and Ganten D. Glucocorticoid- and estrogen-responsive elements in the 5′-flanking region of the rat angiotensinogen gene. J Hypertens 9 (1991) 1005-1012
31. Clauser E., Gaillard I., Wei L., and Corvol P. Regulation of angiotensinogen gene. Am J Hypertens 2 (1989) 403-410
32. Grohé C., Kahlert S., Löbbert K., et al. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. J Hypertens 16 (1998) 377-384
33. Kisley L.R., Sakai R.R., Flanagan-Cato L.M., and Fluharty S.J. Estrogen increases angiotensin II-induced c-Fos expression in the vasopressinergic neurons of the paraventricular nucleus in the female rat. Neuroendocrinology 72 (2000 Nov) 306-317
34. Takeda-Matsubara Y., Nakagami H., Iwai M., et al. Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II. Hypertension 39 (2002) 41-45
35. Xu M.Q., Ye Z., Hu F.B., and He L. Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease. Circulation 116 (2007) 1356-1366
36. Wu S.J., Chiang F.T., Chen W.J., et al. Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype versus haplotype analysis. Physiol Genomics 17 (2004) 79-86
37. Ritchie M.D., Hahn L.W., Roodi N., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69 (2001) 138-147